Abstract
Serotonin receptors—with the exception of the 5-HT3 receptor—are members of the G protein-coupled receptor (GPCR) superfamily. These membrane proteins participate in a wide range of signal transduction pathways. Alterations of their activities often occur in pathological and psychopathological disorders. Therefore, these receptors determine major targets for drug discovery. Currently, the concept of GPCR oligomerization has become widely accepted. Functional heteromers have key significance for receptor expression, ligand binding, signaling, and desensitization. Formation of heteromers among serotonin receptors or between serotonin receptors and other GPCRs enables communication between different protomers within the protein complex and signaling diversification. Receptor heteromers may possess biochemical and pharmacological characteristics that are distinct from those of monomers. Therefore, the knowledge of receptor interaction with their partners has crucial relevance for novel, more selective drug design. The chapter demonstrates the methodology used for the detection of receptor heteromers in heterologous cellular expression systems as well as in native tissues. Evaluation of data focuses on strategies based on the Förster resonance energy transfer (FRET) phenomenon, especially HTRF and FLIM techniques, as well as on proximity ligation assay (PLA) approaches.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bulenger S, Marullo S, Bouvier M (2005) Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol Sci 26:131–137
Kroeger KM, Pfleger KD, Eidne KA (2003) G-protein coupled receptor oligomerization in neuroendocrine pathways. Front Neuroendocrinol 24:254–278
Schlyer S, Horuk R (2006) I want a new drug: G-protein-coupled receptors in drug development. Drug Discov Today 11:481–493
Breit A, Lagacé M, Bouvier M (2004) Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties. J Biol Chem 279:28756–28765
Prinster SC, Hague C, Hall RA (2005) Heterodimerization of G protein-coupled receptors: specificity and functional significance. Pharmacol Rev 57:289–298
Newman-Tancredi A, Kleven M (2011) Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties. Psychopharmacology 216:451–473
de Almeida J, Palacios JM, Mengod G (2008) Distribution of 5-HT and DA receptors in primate prefrontal cortex: implications for pathophysiology and treatment. Prog Brain Res 172:101–115
Meltzer HY, Huang M (2008) In vivo actions of atypical antipsychotic drugs on serotonergic and dopaminergic systems. Prog Brain Res 172:177–197
Maurel D, Kniazeff J, Mathis G, Trinquet E, Pin JP, Ansanay H (2004) Cell surface detection of membrane protein interaction with homogeneous time-resolved fluorescence resonance energy transfer technology. Anal Biochem 329:253–262
Söderberga O, Leuchowiusa KJ, Jarvius M, Gullbergb M, Weibrecht I, Larsson LG, Landegren U (2008) Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. Methods 45(3):227–232
Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 22:1567–1572
Łukasiewicz S, Błasiak E, Faron-Górecka A, Polit A, Tworzydło M, Górecki A, Wasylewski Z, Dziedzicka-Wasylewska M (2007) Fluorescence studies of homooligomerization of adenosine A2A and serotonin 5-HT1A receptors reveal the specificity of receptor interactions in the plasma membrane. Pharmacol Rep 59:379–392
Koushik SV, Chen H, Thaler C, Puhl HL 3rd, Vogel SS (2006) Cerulean, Venus, and VenusY67C FRET reference standards. Biophys J 91:L99–L101
Sambrook J, Fritsch EF, Maniatis T (1996) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York
Boens N, Qin W, Basarić N, Hofkens J, Ameloot M, Pouget J, Lefèvre JP, Valeur B, Gratton E, vandeVen M, Silva ND Jr, Engelborghs Y, Willaert K, Sillen A, Rumbles G, Phillips D, Visser AJ, van Hoek A, Lakowicz JR, Malak H, Gryczynski I, Szabo AG, Krajcarski DT, Tamai N, Miura A (2007) Fluorescence lifetime standards for time and frequency domain fluorescence spectroscopy. Anal Chem 79:2137–2149
Broussard JA, Rappaz B, Webb DJ, Brown CM (2013) Fluorescence resonance energy transfer microscopy as demonstrated by measuring the activation of the serine/threonine kinase Akt. Nat Protoc 8:265–281
Sun Y, Day RN, Periasamy A (2011) Investigating protein-protein interactions in living cells using fluorescence lifetime imaging microscopy. Nat Protoc 6:1324–1340
Borroto-Escuela DO, Romero-Fernandez W, Garriga P, Ciruela F, Narvaez M, Tarakanov AO, Palkovits M, Agnati LF, Fuxe K (2013) G protein-coupled receptor heterodimerization in the brain. Methods Enzymol 521:281–294
Zacharias DA, Violin JD, Newton AC, Tsien RY (2002) Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 296:913–916
Macdonald PJ, Chen Y, Mueller JD (2012) Chromophore maturation and fluorescence fluctuation spectroscopy of fluorescent proteins in a cell-free expression system. Anal Biochem 421:291–298
Acknowledgements
Presented methods are used in projects financed from European Union within Regional Development Fund. Grants for innovation —PARENT/BRIDGE Programme—POMOST/2011-4/5, grant from the Ministry of Science N N401 009640 and JUVENTUS IP2011031571 project.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Łukasiewicz, S., Błasiak, E., Szafran-Pilch, K., Dziedzicka-Wasylewska, M. (2015). Novel Approaches to Serotonin Receptor Interaction Studies. In: Blenau, W., Baumann, A. (eds) Serotonin Receptor Technologies. Neuromethods, vol 95. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2187-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2187-4_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2186-7
Online ISBN: 978-1-4939-2187-4
eBook Packages: Springer Protocols